A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?

There is no question that incretin-based glucose-lowering medications have proven to be effective glucose-lowering agents. Glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate an efficacy comparable to insulin treatment and appear to do so with significant effects to promote weight loss wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Butler, Peter C., Elashoff, Michael, Elashoff, Robert, Gale, Edwin A.M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Diabetes Association 2013
Konular:
Point-Counterpoint
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687282/
https://ncbi.nlm.nih.gov/pubmed/23645885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2713
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller